Evidence map›Paper›PMID 42249001›Full record

ArticleScientific reports2026

Learning multi-granularity skeleton representations via hierarchical graph contrastive learning.

Yaxiong Liu, Xianfeng Zhai

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yaxiong LiuQinghai Normal University, Qinghai, 810000, China.
Xianfeng ZhaiGuangxi Science & Technology Normal University, Guangxi, 546199, China. zhaixianfengok@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skeleton-based action recognition offers inherent robustness to illumination variations and background interference, yet faces challenges such as heavy label reliance, topological destruction during augmentation, and underutilized joint confidence. This paper proposes Hierarchical Graph Contrastive Learning (HGCL), in which the three challenges are addressed in a coupled manner rather than through independently inserted modules. The augmentation strategy combines joint masking, spatial rotation, and Gaussian jittering under a unified topology constraint, with perturbation intensity adapted to the graph distance from core joints and a provable upper bound on bone length deviation. The hierarchical contrastive objective decomposes the InfoNCE loss into a global sequence branch and a part-level branch in which negative pairs are restricted within the same body region, so that local motion signatures and holistic action semantics are jointly optimized rather than entangled at a single granularity. The detection confidence is propagated through both the adjacency matrix used for graph convolution and the pooling operator used for representation aggregation, providing a single mechanism that suppresses unreliable joints throughout the pipeline. Experiments on UCF101 and HMDB51 show that HGCL achieves 91.2% and 66.8% Top-1 accuracy respectively, outperforming InfoGCN by 3.9 and 5.3 percentage points. In 1% few-shot scenarios, HGCL improves upon training-from-scratch by 21.6 percentage points on UCF101. Controlled degradation experiments further demonstrate that the performance advantage of HGCL over baselines widens under increasing coordinate noise and joint occlusion. Feature space analysis reveals a 54.5% reduction in intra-class distance and a 90.3% increase in inter-class distance, validating its effectiveness for self-supervised representation learning.

Identifiers

PMID42249001
PMCPMC13483196

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.